These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26845678)
1. MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10. Liu XF; Wang RQ; Hu B; Luo MC; Zeng QM; Zhou H; Huang K; Dong XH; Luo YB; Luo ZH; Yang H Clin Immunol; 2016 Mar; 164():106-13. PubMed ID: 26845678 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of miR-146a in myasthenia gravis. Lu J; Yan M; Wang Y; Zhang J; Yang H; Tian FF; Zhou W; Zhang N; Li J Neurosci Lett; 2013 Oct; 555():85-90. PubMed ID: 24036458 [TBL] [Abstract][Full Text] [Related]
3. Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis. Zhang Y; Guo M; Xin N; Shao Z; Zhang X; Zhang Y; Chen J; Zheng S; Fu L; Wang Y; Zhou D; Chen H; Huang Y; Dong R; Xiao C; Liu Y; Geng D Clin Exp Med; 2016 Aug; 16(3):413-21. PubMed ID: 25962782 [TBL] [Abstract][Full Text] [Related]
4. Coactivator-associated arginine methyltransferase 1 targeted by miR-15a regulates inflammation in acute coronary syndrome. Liu X; Wang L; Li H; Lu X; Hu Y; Yang X; Huang C; Gu D Atherosclerosis; 2014 Apr; 233(2):349-356. PubMed ID: 24530761 [TBL] [Abstract][Full Text] [Related]
5. miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis. Xin Y; Cai H; Lu T; Zhang Y; Yang Y; Cui Y Biomed Res Int; 2016; 2016():9595718. PubMed ID: 27833920 [No Abstract] [Full Text] [Related]
6. MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis. Weissman R; Diamond EL; Haroche J; Durham BH; Cohen F; Buthorn J; Amoura Z; Emile JF; Mazor RD; Shomron N; Abdel-Wahab OI; Shpilberg O; Hershkovitz-Rokah O Leukemia; 2022 Apr; 36(4):1139-1149. PubMed ID: 34785791 [TBL] [Abstract][Full Text] [Related]
7. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625 [TBL] [Abstract][Full Text] [Related]
8. Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells. Jiang L; Cheng Z; Qiu S; Que Z; Bao W; Jiang C; Zou F; Liu P; Liu J Int Immunopharmacol; 2012 Oct; 14(2):217-23. PubMed ID: 22835429 [TBL] [Abstract][Full Text] [Related]
9. MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia. Chen D; Wu D; Shao K; Ye B; Huang J; Gao Y Am J Transl Res; 2017; 9(9):4308-4316. PubMed ID: 28979704 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma. Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825 [TBL] [Abstract][Full Text] [Related]
11. [Role of miR-155 in myasthenia gravis and effect of dexamethasone on miR-155]. Chen X; Chen Y; Wang Y; Yan M; Zhang J; Liu Q; Yang H; Li J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):777-82. PubMed ID: 22954907 [TBL] [Abstract][Full Text] [Related]
13. Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients. Punga AR; Andersson M; Alimohammadi M; Punga T J Neurol Sci; 2015 Sep; 356(1-2):90-6. PubMed ID: 26095457 [TBL] [Abstract][Full Text] [Related]
14. Pleural fluid mononuclear cells (PFMCs) from tuberculous pleurisy can migrate in vitro in response to CXCL10. Wu C; Ma J; Xu Y; Zhang X; Lao S; Yang B Tuberculosis (Edinb); 2014 Mar; 94(2):123-30. PubMed ID: 24406079 [TBL] [Abstract][Full Text] [Related]
15. [Expression of B7-H3 costimulatory molecule in peripheral blood of myasthenia gravis patients]. Jiang JA; Xue Q; Liu CP; Gao L; Zhang GB; Chen YJ; Zhang XG Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):856-9. PubMed ID: 22863596 [TBL] [Abstract][Full Text] [Related]
16. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF. Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180 [TBL] [Abstract][Full Text] [Related]
17. Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis. Gu M; Kakoulidou M; Giscombe R; Pirskanen R; Lefvert AK; Klareskog L; Wang X Clin Immunol; 2008 Sep; 128(3):374-81. PubMed ID: 18595775 [TBL] [Abstract][Full Text] [Related]
18. Estrogen Downregulates miR-21 Expression and Induces Inflammatory Infiltration of Macrophages in Polymyositis: Role of CXCL10. Yan W; Chen C; Chen H Mol Neurobiol; 2017 Apr; 54(3):1631-1641. PubMed ID: 26873848 [TBL] [Abstract][Full Text] [Related]
19. [Mediation of cellular immune response by TP5 in pathogenesis of myasthenia gravis]. He XT; Liu WB; Zhang Y; Huang X; Huang RX Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3337-40. PubMed ID: 20193562 [TBL] [Abstract][Full Text] [Related]
20. miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice. Shi L; Liu T; Zhang M; Guo Y; Song C; Song D; Liu H Med Sci Monit; 2015 Jun; 21():1774-80. PubMed ID: 26087886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]